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Characterization of Human Osteoarthritic
Cartilage Using Optical and Magnetic
Resonance Imaging
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Sarmad Siddiqui, Xiaojuan Li, Sharmila Majumdar
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Abstract
Purpose: Osteoarthritis (OA) is a degenerative disease starting with key molecular events that
ultimately lead to the breakdown of the cartilage. The purpose of this study is to use two imaging
methods that are sensitive to molecular and macromolecular changes in OA to better
characterize the disease process in human osteoarthritic cartilage.
Procedures: Human femoral condyles were collected from patients diagnosed with severe OA
during total knee replacement surgeries. T1ρ and T2 magnetic resonance measurements were
obtained using a 3-Tesla whole body scanner to assess macromolecular changes in the
damaged cartilage matrix. Optical imaging was performed on specimens treated with
MMPSense 680 to assess the matrix metalloproteinase (MMP) activity. A linear regression
model was used to assess the correlation of MMP optical data with T1ρ magnetic resonance
(MR) measurements. Slices from a representative specimen were removed from regions with
high and low optical signals for subsequent histological analysis.
Results: All specimens exhibit high T1ρ and T2 measurements in the range of 48–75 ms and 36–
69 ms, respectively. They also show intense photon signals (0.376 to 7.89×10−4 cm2) from the
activated MMPSense 680 probe, indicative of high MMP activity. The analysis of variance test of
the regression model indicates a positive correlation between the MMP optical signal and T1ρ
measurements (R2=0.8936, P=0.0044). Histological data also confirmed that regions with high
MMP optical signal and intense T1ρ relaxation exhibit severe clefting, abnormal tidemarks, and
irregular cellularity.
Conclusions: The high T1ρ and T2 measurements suggest that there is a severe loss of
proteoglycans with high water mobility in the damaged cartilage. The intense optical signals
found in these specimens indicate the presence of active MMPs, and the positive correlation
with T1ρ measurements implicates MMP’s involvement in OA progression, characterized by a
severe loss of proteoglycans in the cartilage matrix. The bimodal approach using optical and MR
imaging may provide key molecular and macromolecular information of the disease pathway,
offering insights toward the development of new tools for the early detection, treatment, and/or
prevention of OA.
Key words: Osteoarthritis, Optical imaging, MR imaging, Proteoglycans, Matrix
metalloproteinase
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Osteoarthritis (OA) is a degenerative joint disease thataffects more than 27 million people in the U.S., costing
approximately $34 billion in health care every year [1]. OA is
characterized by degeneration of cartilage in joints. In more
advanced cases, total loss of the cartilage between joints may
cause physical disability. OA is more prevalent in the aging
population, and by the age of 70, approximately 70% of the
population will show radiological evidence of the disease [2].
However, younger people with obesity, occupational stress, or
people who have suffered a traumatic injury are also at risk.
Because there is no effective disease modifying therapy for
OA, it is critical to develop tools for the detection and
characterization of the disease in its early stages, so that the
knowledge gained can be used to devise new regimens to slow
down, reverse, or prevent the process of cartilage degeneration.
Magnetic resonance (MR) imaging of cartilage has been
used widely as a tool for diagnosing joint pathology. It
offers multiplanar image acquisition with high spatial
resolution, giving superior depiction of soft tissue details.
Standard MR imaging is used to assess cartilage damage by
examining the reduction in cartilage thickness or volume. In
OA, these morphological changes are often observed when
the disease has already advanced to its late stages. In the
past, several more complex MR techniques have been
developed to detect and quantify macromolecular changes
in OA [3–5]. For example, T2 relaxation mapping (the spin–
spin relaxation time) predominantly measures the changes in
the collagen component and hydration in the extracellular
matrix [6, 7]. More recently, T1ρ relaxation mapping (the
spin–lattice relaxation time in the rotating frame) has been
correlated with the loss of proteoglycan (PG) macromole-
cules that occurs during the early stages of OA in bovine [8–
10] and human cartilages [11]. Both T2 [12, 13] and T1ρ [14,
15] mapping techniques have been shown to be able to
detect early cartilage degeneration in vivo. These techniques
have shown great promises for the direct and indirect
measurement of macromolecular changes in early cartilage
failure. However, the earliest pathological signaling pathway
that causes macromolecular changes and ultimately struc-
tural–functional degradation is unclear.
Inflammation is recognized as a major contributing
process to both the symptoms and progression of OA [16].
It starts at the molecular level with the activation of key
signaling pathways which results in the breakdown of the
cartilage framework that ultimately leads to irreversible
degeneration. Hence, these signaling pathways are critical
to the onset and progression of the disease. Collective
evidence has indicated that matrix metalloproteinases
(MMPs), a family of zinc-dependent proteolytic enzymes,
are involved in arthritic diseases [17, 18]. Among the family
of 16 secreted and seven membrane-tethered human MMPs,
the gelatinase (MMP-2 and -9) and collagenase (MMP-1 and
-13) subclasses are of particular importance owing to their
ability to digest collagen, basement membranes, and other
macromolecules in the extracellular matrix [19, 20]. These
enzymes are produced as inactive precursors and can
subsequently be activated proteolytically by active MMPs
upon secretion into the extracellular space [21]. In vitro
studies of macrophages and chondrocytes have provided a
more comprehensive molecular mechanism of pro-MMP
production and activation, as well as their concerted
involvement in OA degeneration [22]. Based on this signal-
ing pathway, the upregulation of MMP-9 and -13 are
considered as potential targets for early assessment and
therapeutic intervention for OA.
In the past decade, there has been a rapid growth of
molecularly targeted imaging agents for disease detection
[23]. MMPs have been identified as imaging targets for
inflammation [24], cardiovascular disease [25], and cancer
[26]. The first MMP activatable probe for near-IR (NIR)
optical imaging was described by Weissleder et al. [27].
This “smart” probe comprises a PEGylated poly-(L-lysine)
backbone, self-quenching NIR fluorophores and a peptide
sequence (GPLGVRGKC) susceptible to MMP proteolytic
activities [28]. In the absence of MMPs, the self-quenched
probe is optically silent. Upon proteolytic cleavage, the
peptidic substrate fragments containing the fluorophores are
released from the backbone, and the probe is “turned on”
resulting in significant amplification of the fluorescent signal
at 695 nm. Owing to this activation mechanism, the MMP
probe is regarded as being highly specific and sensitive for
MMP activity in NIR optical imaging.
Although the MMP probe was originally designed to
target MMP-2, further development and optimization by the
commercial supplier (it is now called MMPSense, Perkin
Elmer, Boston, MA) has shown that it is predominantly
activated by MMP-9 and -13, with lower activation by a
number of MMPs including MMP-2, -7, and -12 [29] [30]
(Fig. 1). While MMPSense continues to demonstrate its
ability to detect and define MMP activities in the tumor
microenvironment [31–33] and rheumatoid arthritis [34], the
utility of this probe for the characterization of OA is under
explored. Herein, we present our effort to combine optical
Fig. 1. The overall proteolytic activity of MMPSense in an
enzyme panel showing this probe is predominantly activated
by MMP-9 and -13. Courtesy of VisEn Medical, Inc.
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and MR imaging techniques to characterize both MMP
activity and proteoglycan loss in an attempt to provide a
more comprehensive profile of the degradation process in
human osteoarthritic cartilage.
Materials and Methods
Human Knee Specimen Preparation
Human femoral condyles were collected from patients diagnosed
with severe OA during total knee replacement surgeries at the
UCSF Arthritis and Joint Replacement Center. All specimens (n=6)
were preserved immediately in dry ice, then stored in a −80°C
freezer no later than 3 h post surgery. Prior to imaging experiments,
the specimens were wrapped in gauzes soaked with Lactated
Ringer’s solution (Braun Medical Sciences, Irvine, CA) to curtail
articular cartilage dehydration and stored in a 4°C refrigerator for
2–4 h to thaw.
Ex Vivo MR Imaging
Upon thawing of the specimen, a layer of simithecone (Spectrum
Chemical Manufacturing, Gardena, CA) was applied to the articular
surface of the condyle to reduce biochemical exchanges between
the specimen and surrounding solution and to minimize the
formation of air bubbles. The specimen was then attached to a
plastic grid for spatial reference. The specimen and grid were
fixated into a cylindrical plastic container and immersed in
phosphate-buffered saline (PBS). The total preparation time before
MR imaging was no more than 30 min.
MR imaging was performed on a 3-Tesla whole body scanner
(Signa HDx, GE Healthcare, Milwaukee, WI) using an eight-
channel phased array knee coil (Invivo, Orlando, FL). All speci-
mens were scanned in their respective physiological positions to
simulate their in vivo orientation and position. The sequences used
were (1) T1-weighted three-dimensional high spatial resolution
volumetric fat-suppressed spoiled gradient echo (SPGR) sequence
(TR/TE=20/7.5 ms, 12° flip angle, 512×512 matrix, 0.293×0.293-
mm in-plane spatial resolution, 16-cm field of view, 1-mm section
thickness, number of slices=40; acquisition time of 7 min 37 s); (2)
three-dimensional T1ρ mapping sequence consisted of magnet-
ization preparation for imparting T1ρ contrast and 3-D SPGR
acquisition immediately after the T1ρ preparation during transient
signal evolution [35]. The main parameters used for this sequence
were as follows: TR/TE=9.3/3.7 ms; 14-cm field of view; 256×192
matrix; 2-mm section thickness; number of slices=20; receiver
bandwidth of 31.25 kHz; 48 views per segment; recovery time of
1.5 s; spin-lock times of 0, 10, 40, and 80 ms; and spin-lock
frequency of 500 Hz. The total acquisition time was 12 min 42 s;
(3) Sagittal 3-D T2 maps were acquired by adding a nonselective T2
preparation imaging sequence to the SPGR sequence [36] using
echo times of 4.1, 14.5, 25.0, and 45.9 ms. All other prescription
parameters for the T2 sequence were identical to those used for the
T1ρ sequence, and the total acquisition time was 10 min 36 s.
Ex Vivo Image Processing
After scanning, all MR images were transferred to a computer
workstation (Sun Microsystems, Palo Alto, CA) for offline post-
processing. The T1ρ and T2 maps were reconstructed using an
in-house developed software written in C by fitting the T1ρ-
weighted and T2-weighted images pixel by pixel to the
equations
S TSLð Þ / So  e
TSL
T1
 
; S TEð Þ / S0  e
TE
T2
 
;
respectively, whereas TSL stands for time of spin-lock and TE
stands for echo time, S0 is the signal intensity without T1ρ or T2
weight, and S is signal intensity with T1ρ or T2 weight.
Cartilage was segmented semi-automatically in sagittal SPGR
images using an in-house developed program with MATLAB
(MathWorks, Natick, MA) based on edge detection and Bezier
splines [37]. Three-dimensional region of interests (ROIs) of the
full thickness of cartilage were generated and overlaid onto the
reconstructed T1ρ and T2 maps. The ROI was defined to include the
whole specimen through multiple slices in order to correlate MR
measures with optical measures as detailed below. The mean,
median, and standard deviation of T1ρ and T2 values were
calculated after correcting ROIs to exclude fluid pixels.
Optical Imaging
The matrix metalloproteinase sensing probe (MMPSense 680,
13.3 μM, VisEn Medical, Inc., Bedford, MA) was used to detect
the MMP activity in all OA knee specimens. All specimens were
incubated with MMPSense (diluted to 0.2 μM in PBS) in the
dark at 37°C for 2 h. The resulting specimens were removed,
washed with PBS, and subjected to optical reflectance imaging
(IVIS 50, Caliper Life Sciences, Hopkinton, MA) using
excitation and emission band-pass filters set at 640 nm (±25)
and 733 nm (±37), respectively and a cooled CCD camera (−90°C)
to detect the fluorescence signal emitted by the MMPSense probe at
695 nm. All images were collected using the same field of view
with binning set at 4 s, f-stop at 2 s, and exposure time at 1 s. All
images were adjusted using the same threshold. The ROI was
defined to include the entire specimen. The same criteria were used
to define the ROI for all samples tested. Total photon efficiency,
representing the radiance of the specimen normalized against the
excitation intensity, was measured in the ROIs and subtracted from
background. All optical measurements were tabulated with the T1ρ
and T2 MR measurements. Analysis of variance (ANOVA) was
used to evaluate the linear regression of the optical andMR imaging
data.
Histology
Following ex vivo MR and optical imaging, 3-mm thick sagittal
histological sections were obtained from the same plane as the
sagittal ex vivo MR imaging. In addition, the exact location of
the histology sections was recorded carefully using anatomical
and landmark measurements. Locations to section were selected
based on elevated MMP signals as determined by photon
efficiency in optical imaging. Two sections were obtained for
histological analysis from regions with high and low optical
signals. These sections were fixed in 10% formalin and
embedded in paraffin. Each section spanned the entire sagittal
length of the specimen (approximately 4 cm). The samples
were stained with hematoxylin and eosin (H&E) for morpho-
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logical measurements to give qualitative evaluation of cartilage
degeneration.
Results
MR and Optical Imaging of OA Knee Specimens
Quantitative 3-D T1ρ-weighted imaging of the OA knee
specimens shows mean T1ρ relaxation times ranging from 48
to 75 ms. The corresponding color-coded T1ρ maps overlaid
on the SPGR images (Fig. 2) reveal regions with long
relaxation times and hence severe loss of PGs [15]. In the
same data set, T2-weighted imaging shows long T2 relaxa-
tion times (36–69 ms) in all samples (Table 1). 2-D optical
fluorescence signals from MMPSense show a significant
upregulation of MMP activities in all samples with total
photon efficiency ranging from 3.76×10−5 to 7.89×
10−4 cm2 (Fig. 3b; Table 1). No signal is apparent in the
absence of MMPSense (Fig. 3a). The linear regression
model of optical photon efficiency plotted against MR T1ρ
values shows a positive correlation (correlation coefficient,
R2=0.8936) with increasing optical signal corresponding to
long T1ρ relaxation time (Fig. 4). ANOVA test was applied
to evaluate the regression model. The corresponding P value
was calculated at 0.0044, indicating a significant relationship
between the optical and T1ρ MR measurements. There is no
significant correlation between optical and T2 or T1ρ and T2
measurements.
Histological Analysis
A femoral condyle specimen (K040MPFC) treated with
MMPSense 680 was examined by optical and MR imaging.
A high optical signal was observed in the medial compart-
ment that directly coincides with the long T1ρ relaxation
captured by MR imaging (Fig. 5a, c), whereas the region of
low optical signal corresponds with shorter T1ρ relaxation
time in the lateral compartment (Fig. 5b). Two sample slices
were removed at regions with high and low optical signals
for histological analysis. The corresponding H&E staining
shows that the region with high MMP optical signal has
severe fissuring and clefting, disorganized tidemark as well
as the loss of cellularity (Fig. 5d). On the contrary, the
region with low MMP optical signal shows minimal clefting,
normal tidemark, and normal cellularity (Fig. 5e).
Discussion
From the onset to the progression of OA is a result of
multiple cascading molecular events that lead to the break-
down of macromolecules and ultimately the loss of the
overall structural integrity of the cartilage [38]. Investiga-
tions of early molecular events and macromolecular changes
in OA have helped us to gain a better understanding of the
disease process from cells [22] to animals [39] and humans
[35, 40]. Although these studies are extremely valuable,
there is little evidence of these molecular and macro-
molecular markers working synergistically towards OA
development. For instance, T2 relaxation, which measures
the increasing water mobility in damaged collagen, provides
a glimpse of a degenerative event in an already damaged
collagen network; it reveals no information about the early
proteolytic process that is responsible for collagen degrada-
tion. Of equal importance is the realization that although T1ρ
quantification has been shown to correlate with the loss of
PG macromolecules, such measurements report a disease
process that has already taken place, and earlier biochemical
events that are responsible for the digestion of PG still
remain elusive. The ability to interrogate both molecular and
macromolecular changes in the disease process, therefore,
will not only provide us with a more comprehensive profile
of the degradation mechanism in OA, it may also open new
Fig. 2. A representative image of T1ρ mapping of a human femoral condyle specimen. All specimens were imaged in their
respective physiological positions to simulate the in vivo orientation and position: M medial, L lateral, A anterior, and P
posterior. Images were scanned from medial to lateral positions. Cartilage T1ρ relaxation times (ms) are overlaid with color-
coded SPGR images for visualization.
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avenues for therapeutic targets designed to halt the degen-
erative process at its earliest stages.
Imaging Approach with Optical and MR
Active MMP-9 and -13 are key enzymes that are responsible
for the digestion of collagens and degradation of PGs during
the early stages of OA. Upregulation of MMPs, therefore,
could be an early sign of OA development. In fact,
comprehensive gene profiling using real-time polymerase
chain reaction in both animal [41] and human [42, 43] OA
cartilages have revealed the overexpression of MMP-9 and -
13. In particular, studies using canine elbow bone and
cartilage have shown that the upregulation of MMP-9 and -
13, correlate with radiographic evidence of the disease [41],
suggesting expression of these two proteases may act as a
predictor for OA severity.
The interrogation of proteolytic activities requires a
detection method with high specificity and sensitivity.
Although the peptide sequence on the MMPSense is
sensitive toward a number of MMPs, it is predominantly
cleaved by MMP-9 and -13, making this agent well suited
for probing proteolytic activities in OA. The built-in “on–
off” switch in MMPSense also allows it to have maximum
signal amplification, providing high detection sensitivity
down to picomole concentration [44]. Importantly, because
the optical signal is acquired in the near-IR region,
interference from auto-fluorescence from biological tissues
(such as cartilage and bone) is negligible [45]. The “turned
on” MMP probe, therefore, is a direct measure of the MMP
activity level without any interference from background
signals.
T1ρ quantification has shown great promise as a clinical
tool to characterize cartilage degeneration that cannot be
detected by standard MR imaging techniques. The T1ρ
relaxation represents the slow-motion interactions between
motion-restricted water molecules and their macromolec-
ular environment. Probing for these water molecule
signals with T1ρ reflects macromolecular changes such as
PG loss. Previous studies have reported that T1ρ relaxation
rate (1/T1ρ) correlates with PG concentration in cartilage
[8]. Studies in specimens and in patients have shown
collective evidence of elevated T1ρ in OA cartilage [10,
15, 35, 46–48]. The T2 value in cartilage is known to be
affected by the overall water mobility, collagen content,
and structural features within the ROI. Although it is a
rather less sensitive measurement, elevated T2 values have
been observed in OA [13, 49]. In this study, both T1ρ and
T2 values of the OA knee specimens are relatively high
ranging from 48 to 75 ms and from 36 to 69 ms,
respectively, suggesting the well-recognized heterogeneity
of cartilage degeneration [50].
Table 1. A summary of results from T1ρ relaxation time, T2 relaxation time, and optical measurements of human femoral condyles from patients diagnosed
with severe OA
Specimen Average 3D-T1ρ (ms) Average T2 (ms) Photon efficiency (cm
2)
K040 MPFC 56.16±12.94 40.85±8.65 2.16E-04
K045 LPFC 48.02±15.21 36.22±7.53 3.76E-05
K045 MPFC 58.03±11.02 51.94±22.55 2.13E-04
K050 MPFC 62.93±19.28 43.61±13.33 2.71E-04
K058 LPFC 62.17±11.28 37.87±10.64 4.89E-04
K060 LPFC 74.75±21.88 47.34±12.55 7.89E-04
Fig. 3. A representative optical image of a human OA knee
specimen. The orientation and positioning of the specimen is
as follows: M medial, L lateral, A anterior, and P posterior. a
Before incubation with MMPSense 680 with no detectable
background signal; b after incubation with 0.2 μM of
MMPSense 680 in PBS for 2 h. The intense optical signal
signifies the upregulation of MMP activities.
Fig. 4. The MMP optical signal was plotted against the MR
T1ρ measurement. Six different samples were used. A linear
regression model showing an increase of MMP optical signal
with T1ρ measurement with R
2 at 0.8936. The corresponding
P value was calculated at 0.0044, indicating a significant
relationship of the optical and MR measurements.
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MMP and Proteoglycans
When comparing the optical and MR measurements, we
recognized that the optical reflectance measurement is
limited to providing the overall surface signal from the
specimen without any depth information. During MR image
analysis, instead of measuring each layer of the cartilage
matrix, we opted to measure T1ρ and T2 for the full thickness
of the cartilage to allow for comparable imaging data from
MR and optical.
MMP’s involvement in OA degeneration can be realized
by examining both optical and MR data. From the linear
regression model with MMP activities expressed in normal-
ized photon efficiency plotted against the amount of PG loss
measured by T1ρ, there is a positive correlation between the
two (R2=0.8936, P value of 0.0044). Although the present
study is limited by the lack of direct PG content quantifi-
cation measured by conventional biochemical assays, a
recent study from our group using human osteoarthritic
cartilage (specimens similar to that used in this study)
showed a significant correlation between PG contents and
T1ρ quantification [11]. Collectively, the relationship found
between the optical and MR T1ρ data not only confirms the
presence of active MMPs at the late stage of OA, it also
implicates MMPs’ involvement in PG degradation.
Although T2 measurements give the gross water content of
the knee cartilage, and there is no observable correlation
with T1ρ or the optical data, the high water content suggests
that the collagen matrix is compromised and is contributing
to the overall structural instability and severity of OA in
patients.
Histological Findings
The histological result is best visualized with both optical
and MR data (Fig. 5a–c). Two slices taken from an OA knee
specimen with regions of both high and low MMP activity
(as indicated from the optical imaging) were subjected to
H&E staining. The sample taken from the high MMP region
not only exhibits high T1ρ relaxation, it also displays an
abnormal structure and cellularity by histology, which are
the classic signs of OA. The sample taken from the low
MMP optical region shows a much less intense T1ρ map,
minimal clefting, normal tidemark, and cellularity. Because
cartilage consists of only one cell type [51], chondrocytes,
H&E staining did not reveal any inflammation cell distribu-
tion. Nonetheless, our collective findings suggest a possible
link between increasing MMPs activity and more severe PG
loss and cartilage abnormalities.
Conclusions
In this study, we have demonstrated the utility of optical
imaging with MMPSense to characterize the upregulation of
MMPs in human OA cartilage. Based on the MR T1ρ and T2
measurements, all these specimens have severe PG loss and
high water mobility in the damaged cartilage. The histology
data further confirms the abnormality of the cartilage with
high optical MMP signal and intense T1ρ mapping. The
relationship between the MMP optical data and the T1ρ
measurements also implicates MMP’s involvement in the
OA disease process that ultimately leads to macromolecular
Fig. 5. A femoral condyle (K040MPFC) was treated with
MMPSense 680 and examined by optical and MR imaging.
The optical signal was normalized against the background
excitation and expressed in photon efficiency. The specimen
was imaged in its respective physiological positions to
simulate the in vivo orientation and position: M medial, L
lateral, A anterior, and P posterior. Signals observed here
indicate high MMP activities in the medial compartment (a).
Two slices were removed from high (red) and low (blue)
optical regions for histological analysis. b, c Color-coded T1ρ
maps overlaid on a 3-Tesla MR image with (b) corresponding
to the low optical signal region and (c) corresponding to the
high optical signal region. The T1ρ relaxation value is ranging
from 40 to 60 ms with the highest value coded as red. The
intense T1ρ region signifies the severe loss of proteoglycans.
d, e The hematoxylin and eosin staining showing the region
with low MMP optical signal (d) has minimal clefting, normal
tidemark, and normal cellularity. On the contrary, the region
with high MMP optical signal exhibits severe fissuring and
clefting, disorganized tidemark as well as the loss of
cellularity.
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PG degradation. Further investigations combining optical
and MR imaging of OA may yield useful molecular and
macromolecular information of the disease pathway, offer-
ing insights to new tool development for OA early detection,
treatment, and/or prevention.
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